Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. (Q35889626)
Jump to navigation
Jump to search
scientific article published on 30 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. |
scientific article published on 30 November 2011 |
Statements
1 reference
Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. (English)
1 reference
Tsutomu Takashima
1 reference
Shinichiro Kashiwagi
1 reference
Masakazu Yashiro
1 reference
Naoki Aomatsu
1 reference
Katsumi Ikeda
1 reference
Yoshinari Ogawa
1 reference
Tetsuro Ishikawa
1 reference
Kosei Hirakawa
1 reference
30 November 2011
1 reference
1 reference
R122
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference